dried up nationwide and under pressure from the White House, Abbott entered a consent decree with the FDA that laid out the steps needed to resume production at the facility.
Abbott said it will start production of EleCare and other specialty and metabolic formulas and the initial product release to consumers is expected to begin on June 20. But the production of Similac and other formulas is still on pause, Abbott said.The Abbott manufacturing facility in Sturgis, Michigan, on May 13, 2022. - Abbott representatives announced on Wednesday that the Sturgis plant could reopen within the next two weeks, subject to FDA approval.
AFTER EXTORTING no Prosecution for shipping unsafe formula killing 2 babies.
WCCO Lol
I 🙏🏻 that kind souls prepped these baby formulas w/goid hearts & not malice & sabotage of these imported goods.